BioSpace News Archive

Business

Edwards Lifesciences Reports Third Quarter 2018 Results

Edwards Lifesciences Corporation today reported financial results for the quarter ended September 30, 2018.

October 23, 2018
·
26 min read
Mallinckrodt and the Lupus Foundation of America Present Data from Survey of Over 1,500 Individuals with Self-Reported Lupus at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting

Study finds individuals with lupus experience a high disease flare burden and as a result engage in preventive and treatment measures

October 23, 2018
·
8 min read
Deals

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) on October 17, 2018

PTC Therapeutics, Inc. today announced that on October 17, 2018 it approved non-statutory stock options to purchase an aggregate of 68,700 shares of its common stock to 13 new employees.

October 23, 2018
·
1 min read
Business

Marker Therapeutics, Inc. Announces New Executive Appointments

Marker Therapeutics, Inc. today announced the addition of four senior executives to its executive management team.

October 23, 2018
·
8 min read
BioForest

Evolent Health, Inc. Announces Exercise of Option to Purchase Additional Convertible Senior Notes Due 2025

Evolent Health, Inc. today announced that, in connection with its offering of 1.50% convertible senior notes due 2025 (the “notes”), the initial purchasers have exercised in full their option to purchase an additional $22.5 million aggregate principal amount of the notes.

October 23, 2018
·
4 min read
Business

Vivex Biomedical, Inc. announces Lisa Colleran as the new CEO of the company

Vivex Biomedical, a leading Regenerative Medicine company, announced today that Lisa Colleran has been appointed the new CEO.

October 23, 2018
·
3 min read
Business

Lexogen supports thousands of RNA researchers worldwide by partnering with the RNA Society in their 2018/19 RNA Salon initiative

RNA (ribonucleic acid) is one of the most important building blocks of life, and this molecule is researched in diverse biological disciplines.

October 23, 2018
·
2 min read
Biotech Beach

Men’s Health Features Glowing Reviews for Medical Marijuana, Inc. Subsidiary HempMeds® Products

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® has garnered news coverage in leading international publication Men’s Health.

October 23, 2018
·
4 min read
Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Osphena (ospemifene) to U.S. FDA Seeking Approval for the Treatment of Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause

Duchesnay Inc., a pharmaceutical company specializing in women’s health, announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) seeking a new indication for Osphena® (ospemifene).

October 23, 2018
·
5 min read
BioForest

Jama Software Introduces Product Enhancements and New Service Capabilities to Help Companies Navigate the Growing Complexity of Medical Device Development

Jama Software, the leading product development platform provider for building complex products and integrated systems, today announced the launch of the Jama Connect™ Risk Management Center and Jama Medical Device Services

October 23, 2018
·
3 min read